2017 Q3 Form 10-Q Financial Statement

#000117184317006564 Filed on November 02, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2016 Q3
Revenue $18.72M $25.01M
YoY Change -25.15% -2.81%
Cost Of Revenue $9.217M $13.32M
YoY Change -30.79% -4.91%
Gross Profit $9.500M $11.69M
YoY Change -18.73% -0.31%
Gross Profit Margin 50.76% 46.75%
Selling, General & Admin $7.950M $9.810M
YoY Change -18.96% -2.22%
% of Gross Profit 83.68% 83.92%
Research & Development $1.540M $1.309M
YoY Change 17.65% -8.2%
% of Gross Profit 16.21% 11.2%
Depreciation & Amortization $990.0K $1.090M
YoY Change -9.17% 2.83%
% of Gross Profit 10.42% 9.32%
Operating Expenses $9.890M $12.50M
YoY Change -20.9% 0.02%
Operating Profit -$390.0K -$813.0K
YoY Change -52.03% 4.9%
Interest Expense $189.0K $142.0K
YoY Change 33.1% -30.39%
% of Operating Profit
Other Income/Expense, Net -$274.0K -$67.00K
YoY Change 308.96% -79.13%
Pretax Income -$664.0K -$880.0K
YoY Change -24.55% -19.71%
Income Tax -$19.00K $758.0K
% Of Pretax Income
Net Earnings -$417.0K -$1.638M
YoY Change -74.54% 93.39%
Net Earnings / Revenue -2.23% -6.55%
Basic Earnings Per Share -$0.01 -$0.05
Diluted Earnings Per Share -$0.01 -$0.05
COMMON SHARES
Basic Shares Outstanding 34.84M shares 34.33M shares
Diluted Shares Outstanding 34.84M shares 34.33M shares

Balance Sheet

Concept 2017 Q3 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.800M $5.300M
YoY Change 9.43% -13.11%
Cash & Equivalents $5.836M $5.345M
Short-Term Investments
Other Short-Term Assets $4.463M
YoY Change -11.97%
Inventory $21.40M $21.20M
Prepaid Expenses
Receivables $15.27M $15.12M
Other Receivables $4.900M $4.500M
Total Short-Term Assets $47.40M $46.15M
YoY Change 2.7% -11.79%
LONG-TERM ASSETS
Property, Plant & Equipment $4.300M $5.267M
YoY Change -18.36% -11.24%
Goodwill $39.84M $39.62M
YoY Change 0.54% -3.02%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.400M $112.0K
YoY Change 1150.0% -67.91%
Total Long-Term Assets $63.30M $66.02M
YoY Change -4.12% -18.72%
TOTAL ASSETS
Total Short-Term Assets $47.40M $46.15M
Total Long-Term Assets $63.30M $66.02M
Total Assets $110.7M $112.2M
YoY Change -1.32% -16.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.607M $6.142M
YoY Change -8.71% -2.85%
Accrued Expenses $4.500M $4.501M
YoY Change -0.02% 17.21%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.800M $2.400M
YoY Change 16.67% -52.0%
Total Short-Term Liabilities $13.90M $14.44M
YoY Change -3.75% -16.38%
LONG-TERM LIABILITIES
Long-Term Debt $9.700M $12.67M
YoY Change -23.43% -16.38%
Other Long-Term Liabilities $3.500M $2.600M
YoY Change 34.62% -43.48%
Total Long-Term Liabilities $13.20M $12.67M
YoY Change 4.2% -16.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.90M $14.44M
Total Long-Term Liabilities $13.20M $12.67M
Total Liabilities $33.80M $36.29M
YoY Change -6.85% -7.6%
SHAREHOLDERS EQUITY
Retained Earnings -$114.7M
YoY Change 21.28%
Common Stock $417.0K
YoY Change -99.8%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 7.746M shares
Shareholders Equity $76.90M $75.89M
YoY Change
Total Liabilities & Shareholders Equity $110.7M $112.2M
YoY Change -1.32% -16.01%

Cashflow Statement

Concept 2017 Q3 2016 Q3
OPERATING ACTIVITIES
Net Income -$417.0K -$1.638M
YoY Change -74.54% 93.39%
Depreciation, Depletion And Amortization $990.0K $1.090M
YoY Change -9.17% 2.83%
Cash From Operating Activities $2.140M $3.440M
YoY Change -37.79% -4400.0%
INVESTING ACTIVITIES
Capital Expenditures -$240.0K -$540.0K
YoY Change -55.56% -18.18%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$240.0K -$540.0K
YoY Change -55.56% -19.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -720.0K -1.030M
YoY Change -30.1% 151.22%
NET CHANGE
Cash From Operating Activities 2.140M 3.440M
Cash From Investing Activities -240.0K -540.0K
Cash From Financing Activities -720.0K -1.030M
Net Change In Cash 1.180M 1.870M
YoY Change -36.9% -261.21%
FREE CASH FLOW
Cash From Operating Activities $2.140M $3.440M
Capital Expenditures -$240.0K -$540.0K
Free Cash Flow $2.380M $3.980M
YoY Change -40.2% 586.21%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
36000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2017Q3 us-gaap Interest Expense
InterestExpense
189000 USD
CY2017Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12000 USD
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-64000 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
2604000 USD
us-gaap Depreciation
Depreciation
1009000 USD
hbio Amortization Of Catalog Costs
AmortizationOfCatalogCosts
31000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
608000 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
563000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-786000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
35000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-830000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
99000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
7000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1996000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-716000 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
2250000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3502000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-101000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1353000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
313000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
240000 USD
us-gaap Interest Paid
InterestPaid
503000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
-96000 USD
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3625000 USD
CY2017Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
9737000 USD
CY2017Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
875000 USD
CY2017Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
10768000 USD
CY2017Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20656000 USD
CY2017Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16391000 USD
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1739000 USD
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1740000 USD
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1537000 USD
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1151000 USD
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1133000 USD
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
1879000 USD
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
9179000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2500000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2400000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2200000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2200000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2200000 USD
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
1181000 USD
CY2016Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-2006000 USD
CY2017Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
0 USD
CY2016Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
11000 USD
CY2017Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-21000 USD
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
785000 USD
CY2017Q3 hbio Total Indefinite Lived Intangible Assets Including Goodwill
TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill
41077000 USD
CY2017Q3 hbio Total Intangible Assets
TotalIntangibleAssets
88742000 USD
CY2017Q3 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
141000 USD
CY2017Q3 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
179000 USD
CY2017Q3 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-98000 USD
CY2017Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
60000 USD
CY2017Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
248000 USD
CY2016Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
193000 USD
CY2016 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
97000 USD
CY2016 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
143000 USD
dei Entity Central Index Key
EntityCentralIndexKey
0001123494
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-43000 USD
CY2017Q3 us-gaap Secured Debt
SecuredDebt
12439000 USD
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18904000 USD
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14608000 USD
CY2016Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
9340000 USD
CY2016Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
823000 USD
CY2016Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
9792000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
47665000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-31122000 USD
CY2016Q4 hbio Total Indefinite Lived Intangible Assets Including Goodwill
TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill
39241000 USD
CY2016Q4 hbio Total Intangible Assets
TotalIntangibleAssets
84882000 USD
CY2015Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
147000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1293771 shares
CY2015Q2 hbio Increase In Number Of Shares Authorized For Issuance Under Stock Option And Incentive Plan
IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan
2500000 shares
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
45641000 USD
CY2016Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-67000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-28170000 USD
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4096818 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1072653 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
3.15
CY2016Q3 us-gaap Revenues
Revenues
25007000 USD
CY2016Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13317000 USD
CY2016Q3 us-gaap Gross Profit
GrossProfit
11690000 USD
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
12503000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-813000 USD
CY2016Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y0M30D
CY2017Q3 us-gaap Share Based Compensation
ShareBasedCompensation
933000 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-880000 USD
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
758000 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-1638000 USD
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div><p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' >2</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >.</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' > Recently Issued Accounting Pronouncements</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Calibri;font-size:11pt;font-weight:bold;margin-left:0pt;' > </font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >Revenue</font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' > from Contracts with Customers, </font><font style='font-family:Times New Roman;font-size:10pt;' >a</font><font style='font-family:Times New Roman;font-size:10pt;' > new accounting standard that provides for a comprehensive model to use in the accounting for revenue arising from contracts with customers that will replace most existing revenue recognition guidance within generally accepted accounting principles in the </font><font style='font-family:Times New Roman;font-size:10pt;' >United States. Under this standard, revenue will be recognized to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or service</font><font style='font-family:Times New Roman;font-size:10pt;' >s. </font><font style='font-family:Times New Roman;font-size:10pt;' >The Company expects to adopt this standard as of January 1, 2018 using the modified retrospective approach.</font><font style='font-family:Times New Roman;font-size:10pt;' > </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >The Company</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >is in the process of evaluating the impact of the new standard on </font><font style='font-family:Times New Roman;font-size:10pt;' >its consolidated financial position, results of operations and cash</font><font style='font-family:Times New Roman;font-size:10pt;' > flows</font><font style='font-family:Times New Roman;font-size:10pt;' >. As part of this process, the Company has conducted</font><font style='font-family:Times New Roman;font-size:10pt;' > a comprehensive ass</font><font style='font-family:Times New Roman;font-size:10pt;' >essment of its contracts</font><font style='font-family:Times New Roman;font-size:10pt;' > concerning any unique customer contract terms o</font><font style='font-family:Times New Roman;font-size:10pt;' >r transactions that could have implications </font><font style='font-family:Times New Roman;font-size:10pt;' >under the new guidance.</font><font style='font-family:Times New Roman;font-size:10pt;' > T</font><font style='font-family:Times New Roman;font-size:10pt;' >he Company has identified its </font><font style='font-family:Times New Roman;font-size:10pt;' >significant</font><font style='font-family:Times New Roman;font-size:10pt;' > revenue streams, which</font><font style='font-family:Times New Roman;font-size:10pt;' > currently consist primarily</font><font style='font-family:Times New Roman;font-size:10pt;' > of </font><font style='font-family:Times New Roman;font-size:10pt;' >product</font><font style='font-family:Times New Roman;font-size:10pt;' > revenue transactions, </font><font style='font-family:Times New Roman;font-size:10pt;' >and to a lesser extent, </font><font style='font-family:Times New Roman;font-size:10pt;' >extended warranty </font><font style='font-family:Times New Roman;font-size:10pt;' >transactions on certain product </font><font style='font-family:Times New Roman;font-size:10pt;' >sales, and revenues </font><font style='font-family:Times New Roman;font-size:10pt;' >from</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >government contract</font><font style='font-family:Times New Roman;font-size:10pt;' >s. T</font><font style='font-family:Times New Roman;font-size:10pt;' >he Company is in the process of updating its revenue </font><font style='font-family:Times New Roman;font-size:10pt;' >recognition</font><font style='font-family:Times New Roman;font-size:10pt;' > policy, systems,</font><font style='font-family:Times New Roman;font-size:10pt;' > and </font><font style='font-family:Times New Roman;font-size:10pt;' >internal </font><font style='font-family:Times New Roman;font-size:10pt;' >controls in response to the new update. T</font><font style='font-family:Times New Roman;font-size:10pt;' >he Company does not expect material changes to the timing of</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >revenue recognition, nor does it expect significant changes to its</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >systems or internal controls</font><font style='font-family:Times New Roman;font-size:10pt;' >. </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >Finally, t</font><font style='font-family:Times New Roman;font-size:10pt;' >he Company is evaluating the disclosure requirements under the new standard, which are generally more expansive than current guidance. </font><font style='font-family:Times New Roman;font-size:10pt;' >The Company expects these</font><font style='font-family:Times New Roman;font-size:10pt;' > undertaking</font><font style='font-family:Times New Roman;font-size:10pt;' >s</font><font style='font-family:Times New Roman;font-size:10pt;' > will be complete in </font><font style='font-family:Times New Roman;font-size:10pt;' >the fourth quarter</font><font style='font-family:Times New Roman;font-size:10pt;' > of 2017.</font><font style='font-family:Times New Roman;font-size:10pt;' > Based on procedures to date, the C</font><font style='font-family:Times New Roman;font-size:10pt;' >ompany does not anticipate material changes </font><font style='font-family:Times New Roman;font-size:10pt;' >to its consolidated financial s</font><font style='font-family:Times New Roman;font-size:10pt;' >tatements</font><font style='font-family:Times New Roman;font-size:10pt;' >. The Company continues to work through the adoption process and it is possible that these preliminary conclusions could change. </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In February 2016, the FASB issued ASU 201</font><font style='font-family:Times New Roman;font-size:10pt;' >6-02, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >Leases</font><font style='font-family:Times New Roman;font-size:10pt;' >, which is intended to improve financial reporting about leasing transactions. The update requires a lessee to record on the balance sheet the assets and liabilities for the rights and obligations created by lease terms of more than 12&#160;months. </font><font style='font-family:Times New Roman;font-size:10pt;' >The update is effective for fiscal years beginning after December 15, 2018. </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >The Company has commenced the process of evaluating the requirements of the standard as well as collecting information on all its leases. The Company has not yet concluded on the </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >impact of the adoption on its consolidated financial position, results of operations and cash flows, however, assets and liabilities will increase upon adoption for right-of-use assets and lease liabilities. The Company&#8217;s future commitments under lease obl</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >igations are summarized in Note 10.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In May </font><font style='font-family:Times New Roman;font-size:10pt;' >2017, the FASB issued ASU 2017-09,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >Stock compensation (Topic 718): Scope of modification accounting </font><font style='font-family:Times New Roman;font-size:10pt;' >which amends the scope of modification accounting for share-based payment arrangements. The ASU provides </font><font style='font-family:Times New Roman;font-size:10pt;' >guidance on the types of changes to the terms or conditions of share-based payment awards to which an entity would be required to apply modification accounting under ASC 718. Specifically, an entity would not apply modification accounting if the fair value</font><font style='font-family:Times New Roman;font-size:10pt;' >, vesting conditions, and classification of the awards are the same immediately before and after the modification. </font><font style='font-family:Times New Roman;font-size:10pt;' >The</font><font style='font-family:Times New Roman;font-size:10pt;' > ASU is effective for annual reporting periods, including interim periods within those annual reporting periods, beginning after December </font><font style='font-family:Times New Roman;font-size:10pt;' >15, 2017. Early adoption is permitted, including adoption in any interim period.</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >The Company has evaluated the requirements of this guidance and does not expect the adoption of the standard to have a material impact on its consolidated financial position, </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >results of operations and cash flows.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In August</font><font style='font-family:Times New Roman;font-size:10pt;' > 201</font><font style='font-family:Times New Roman;font-size:10pt;' >7, the FASB issued ASU 2017-12, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >Derivatives and Hedging (Topic 815)</font><font style='font-family:Times New Roman;font-size:10pt;' > which amends the hedge accounting recognition and presentation requirements in ASC 815. The Board&#8217;s objectives in issuing the ASU are to</font><font style='font-family:Times New Roman;font-size:10pt;' > (1) improve the transparency and understandability of information conveyed to financial statement users about an entity&#8217;s risk management activities by better aligning the entity&#8217;s financial reporting for hedging relationships with those risk management a</font><font style='font-family:Times New Roman;font-size:10pt;' >ctivities and (2) reduce the complexity of and simplify the application o</font><font style='font-family:Times New Roman;font-size:10pt;' >f hedge accounting by preparers. The</font><font style='font-family:Times New Roman;font-size:10pt;' > ASU is effective for annual reporting periods, including interim periods within those annual reporting periods, beginning after December 15, 201</font><font style='font-family:Times New Roman;font-size:10pt;' >8</font><font style='font-family:Times New Roman;font-size:10pt;' >.</font><font style='font-family:Times New Roman;font-size:10pt;' > Early adoption is permitted, including adoption in any interim period.</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >The Company is evaluating the requirements of this guidance and has not yet determined the impact of the adoption on its consolidated financial position, results of operations and cash</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > flows.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:24.5pt;' >Recently Adopted Accounting Pronouncements</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In March 2016, the FASB issued ASU 2016-09,&#160;Compensation &#8211; Stock Compensation (Topic 718): </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >Improvements to Employee Share-Based Payment Accounting</font><font style='font-family:Times New Roman;font-size:10pt;' >, which simplifies the accounting for share-based payment</font><font style='font-family:Times New Roman;font-size:10pt;' > transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >The standard requires an entity to recognize all excess tax benefits and tax deficiencies as</font><font style='font-family:Times New Roman;font-size:10pt;' > income tax benefit or expense in the income statement as discrete items in the reporting period in which they occur, and such tax benefits and tax deficiencies are not included in the estimate of an entity&#8217;s annual effective tax rate, applied on a prospec</font><font style='font-family:Times New Roman;font-size:10pt;' >tive basis. Further, the standard eliminates the requirement to defer the recognition of excess tax benefits until the benefit is realized through a reduction to taxes payable. All excess tax benefits previously unrecognized, along with any valuation allow</font><font style='font-family:Times New Roman;font-size:10pt;' >ance, should be recognized on a modified retrospective basis as a cumulative adjustment to retained earnings as of the </font><font style='font-family:Times New Roman;font-size:10pt;' >date of adoption. Under ASU </font><font style='font-family:Times New Roman;font-size:10pt;' >2016-09, an entity that applies the treasury stock method in calculating diluted earnings per share is requir</font><font style='font-family:Times New Roman;font-size:10pt;' >ed to exclude excess tax benefits and deficiencies from the calculation of assumed proceeds since such amounts are recognized in the income statement. Excess tax benefits should also be classified as operating activities in the same manner as other cash fl</font><font style='font-family:Times New Roman;font-size:10pt;' >ows related to income taxes on the statement of cash flows, as such excess tax benefits no longer represent financing activities since they are recognized in the income statement, and should be applied prospectively or retrospectively to all periods presen</font><font style='font-family:Times New Roman;font-size:10pt;' >ted. </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >The Company adopted ASU 2016-09 as of January 1, 2017. The Company recorded a cumulative increase in retained earnings of $0.5 million at the beginning of the first quarter of 2017 with a corresponding increase in deferred tax assets related to th</font><font style='font-family:Times New Roman;font-size:10pt;' >e prior years&#8217; unrecognized excess tax benefits. An equal amount of valuation allowance was also recorded against these deferred tax assets with a corresponding decrease to retained earnings resulting in no net impact to retained earnings and deferred tax </font><font style='font-family:Times New Roman;font-size:10pt;' >assets. In addition, tax deficiencies related to vested restricted stock units and canceled stock options during the </font><font style='font-family:Times New Roman;font-size:10pt;' >nine months ended</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >September 30,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >2017</font><font style='font-family:Times New Roman;font-size:10pt;' > have been recognized in the current period&#8217;s income statement. </font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >ASU </font><font style='font-family:Times New Roman;font-size:10pt;' >2016-09 also allows an enti</font><font style='font-family:Times New Roman;font-size:10pt;' >ty to elect as an accounting policy either to continue to estimate the total number of awards for which the requisite service period will not be rendered or to account for forfeitures for service based awards as they occur. An entity that elects to account</font><font style='font-family:Times New Roman;font-size:10pt;' > for forfeitures as they occur should apply the accounting change on a modified retrospective basis as a cumulative effect adjustment to retained earnings as of the date of adoption. The Company elected as an accounting policy to account for forfeitures fo</font><font style='font-family:Times New Roman;font-size:10pt;' >r service based awards as they occur, and as a result, the Company recorded a cumulative effect adjustment of $0.1 million to reduce retained earnings with a corresponding increase in additional paid in capital related to the prior years</font><font style='font-family:Times New Roman;font-size:10pt;' >&#8217; stock-based compe</font><font style='font-family:Times New Roman;font-size:10pt;' >nsation expense</font><font style='font-family:Times New Roman;font-size:10pt;' > as required under the modified retrospective approach. </font><font style='font-family:Times New Roman;font-size:10pt;' > The tax effect of this adjustment, which included the impact of a valuation allowance was immaterial. </font></p><p style='text-align:left;line-height:12pt;' ></p></div>
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
21000 USD
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
76000 USD
CY2016Q3 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
156000 USD
CY2016Q3 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
168000 USD
CY2016Q3 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-74000 USD
CY2016Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
62000 USD
CY2017Q3 us-gaap Defined Benefit Plans Estimated Future Employer Contributions In Current Fiscal Year
DefinedBenefitPlansEstimatedFutureEmployerContributionsInCurrentFiscalYear
100000 USD
CY2016Q3 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
200000 USD
CY2017Q3 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
200000 USD
CY2017Q3 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
3400000 USD
CY2016Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
3000000 USD
CY2017Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5789838 shares
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5300945 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
17508929 shares
CY2017Q3 hbio Weighted Average Estimated Black Scholes Value Of Option Grants
WeightedAverageEstimatedBlackScholesValueOfOptionGrants
1.24
CY2016Q3 hbio Weighted Average Estimated Black Scholes Value Of Option Grants
WeightedAverageEstimatedBlackScholesValueOfOptionGrants
1.11
dei Document Period End Date
DocumentPeriodEndDate
2017-09-30
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
hbio Estimated Rental Expenses Current Year
EstimatedRentalExpensesCurrentYear
1900000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1400000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.027 pure
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4305 pure
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0101 pure
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y1M6D
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
762141 shares
hbio Additions To Catalog Costs
AdditionsToCatalogCosts
-39000 USD
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.99
CY2016Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
3.94
CY2017Q3 us-gaap Revenues
Revenues
25050000 USD
CY2017Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13411000 USD
CY2017Q3 us-gaap Gross Profit
GrossProfit
11639000 USD
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
11775000 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-136000 USD
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-274000 USD
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-410000 USD
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-417000 USD
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
2596000 USD
us-gaap Depreciation
Depreciation
1173000 USD
hbio Amortization Of Catalog Costs
AmortizationOfCatalogCosts
13000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
72000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
455000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2145000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-735000 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
742000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-2785000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-158000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
296000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
29000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-954000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
6738000 USD
us-gaap Interest Paid
InterestPaid
468000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
725000 USD
CY2016Q3 us-gaap Share Based Compensation
ShareBasedCompensation
943000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-16658000 USD
CY2017Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12515000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
1805000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4143000 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
4100000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15746000 USD
CY2016Q4 us-gaap Inventory Net
InventoryNet
19955000 USD
CY2017Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15266000 USD
CY2017Q3 us-gaap Goodwill
Goodwill
39837000 USD
CY2016Q4 us-gaap Goodwill
Goodwill
38032000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
17471000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
16543000 USD
CY2017Q3 us-gaap Secured Debt Current
SecuredDebtCurrent
2765000 USD
CY2017Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5607000 USD
CY2017Q2 hbio Lender Approval To Fund Acquisition With Cash Promissory Note In Excess Of Threshold
LenderApprovalToFundAcquisitionWithCashPromissoryNoteInExcessOfThreshold
6000000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
80000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3658000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-443000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1399000 USD
hbio Additions To Catalog Costs
AdditionsToCatalogCosts
-34000 USD
CY2017Q2 hbio Lender Approval To Fund Acquisition With Equity In Excess Of Threshold
LenderApprovalToFundAcquisitionWithEquityInExcessOfThreshold
10000000 USD
CY2016Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
5400000 USD
CY2016Q4 hbio Delayed Drawdown Term Loan
DelayedDrawdownTermLoan
4400000 USD
CY2016Q4 hbio Revolving Credit Facility
RevolvingCreditFacility
4050000 USD
CY2016Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
104000 USD
CY2017Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
12598000 USD
CY2017Q3 hbio Delayed Drawdown Term Loan
DelayedDrawdownTermLoan
0 USD
CY2017Q3 hbio Revolving Credit Facility
RevolvingCreditFacility
0 USD
CY2017Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
159000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
3.09
CY2016Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
729000 USD
CY2017Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
622000 USD
us-gaap Revenues
Revenues
78106000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
41796000 USD
us-gaap Gross Profit
GrossProfit
36310000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15194000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15979000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4236000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2099000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
411000 USD
us-gaap Interest Expense
InterestExpense
484000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-143000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-216000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2090000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
897000 USD
us-gaap Net Income Loss
NetIncomeLoss
-2987000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1390000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-37000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-31000 USD
us-gaap Revenues
Revenues
74419000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
39994000 USD
us-gaap Gross Profit
GrossProfit
34425000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15111000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14144000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4119000 USD
us-gaap Operating Expenses
OperatingExpenses
38184000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1874000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-488000 USD
us-gaap Interest Expense
InterestExpense
531000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-51000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
4189000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-89000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-43000 USD
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
399000 USD
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
505000 USD
us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-276000 USD
us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-233000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
170000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
195000 USD
us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
600000 USD
us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
500000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1400000 USD
CY2017Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000 USD
CY2016Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2596000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2604000 USD
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34156606 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34156606 shares
us-gaap Operating Expenses
OperatingExpenses
35199000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-774000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1141000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-122000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1915000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1864000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34705947 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34705947 shares
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5836000 USD
hbio Libor Fixed Rate
LiborFixedRate
0.0186 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y2M15D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y1M29D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.413 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0188 pure
hbio Weighted Average Estimated Black Scholes Value Of Option Grants
WeightedAverageEstimatedBlackScholesValueOfOptionGrants
1.17
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Offering Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate
0.85 pure
CY2017Q3 hbio Percentage Of Outstanding Common Stock
PercentageOfOutstandingCommonStock
0.2 pure
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5789838 shares
CY2016Q3 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
39353 shares
CY2017Q3 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
36902 shares
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
762141 shares
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.429 pure
us-gaap Cumulative Effect On Retained Earnings Before Tax1
CumulativeEffectOnRetainedEarningsBeforeTax1
100000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1825000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
hbio Non Cash Restructuring Charge
NonCashRestructuringCharge
0 USD
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5345000 USD
CY2017Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2016Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
676000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
676000 USD
hbio Non Cash Restructuring Charge
NonCashRestructuringCharge
-27000 USD
hbio Weighted Average Estimated Black Scholes Value Of Option Grants
WeightedAverageEstimatedBlackScholesValueOfOptionGrants
1.21
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5300945 shares
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
920000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
677000 USD

Files In Submission

Name View Source Status
0001171843-17-006564-index-headers.html Edgar Link pending
0001171843-17-006564-index.html Edgar Link pending
0001171843-17-006564.txt Edgar Link pending
0001171843-17-006564-xbrl.zip Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
exh_322.htm Edgar Link pending
f10q_110217.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hbio-20170930.xml Edgar Link completed
hbio-20170930.xsd Edgar Link pending
hbio-20170930_cal.xml Edgar Link unprocessable
hbio-20170930_def.xml Edgar Link unprocessable
hbio-20170930_lab.xml Edgar Link unprocessable
hbio-20170930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending